Year |
Citation |
Score |
2019 |
Wright GEB, Collins JA, Kay C, McDonald C, Dolzhenko E, Xia Q, Bečanović K, Drögemöller BI, Semaka A, Nguyen CM, Trost B, Richards F, Bijlsma EK, Squitieri F, Ross CJD, et al. Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease. American Journal of Human Genetics. PMID 31104771 DOI: 10.1016/J.Ajhg.2019.04.007 |
0.6 |
|
2019 |
Austin J, Semaka A, Hyunh S. GENETIC COUNSELING AS A WAY TO ENGAGE PEOPLE IN BEHAVIOUR CHANGE TO REDUCE RISK FOR COMMON COMPLEX DISEASE: RATIONALE FOR ITS POTENTIAL EFFECTIVENESS WHERE GENETIC INFORMATION HAS FAILED European Neuropsychopharmacology. 29: S1029. DOI: 10.1016/J.Euroneuro.2018.07.018 |
0.408 |
|
2018 |
Kay C, Collins JA, Wright GEB, Baine F, Miedzybrodzka Z, Aminkeng F, Semaka AJ, McDonald C, Davidson M, Madore SJ, Gordon ES, Gerry NP, Cornejo-Olivas M, Squitieri F, Tishkoff S, et al. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 29460498 DOI: 10.1002/Ajmg.B.32618 |
0.509 |
|
2015 |
Andrighetti H, Semaka A, Stewart SE, Shuman C, Hayeems R, Austin J. Obsessive-Compulsive Disorder: The Process of Parental Adaptation and Implications for Genetic Counseling. Journal of Genetic Counseling. PMID 26639756 DOI: 10.1007/S10897-015-9914-9 |
0.34 |
|
2015 |
Semaka A, Kay C, Belfroid RD, Bijlsma EK, Losekoot M, van Langen IM, van Maarle MC, Oosterloo M, Hayden MR, van Belzen MJ. A new mutation for Huntington disease following maternal transmission of an intermediate allele. European Journal of Medical Genetics. 58: 28-30. PMID 25464109 DOI: 10.1016/J.Ejmg.2014.11.005 |
0.609 |
|
2014 |
Austin J, Semaka A, Hadjipavlou G. Conceptualizing genetic counseling as psychotherapy in the era of genomic medicine. Journal of Genetic Counseling. 23: 903-9. PMID 24841456 DOI: 10.1007/S10897-014-9728-1 |
0.366 |
|
2014 |
Semaka A, Hayden MR. Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results Clinical Genetics. 85: 303-311. PMID 24256063 DOI: 10.1111/Cge.12324 |
0.62 |
|
2013 |
Semaka A, Kay C, Doty CN, Collins JA, Tam N, Hayden MR. High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 864-71. PMID 24038799 DOI: 10.1002/Ajmg.B.32193 |
0.623 |
|
2013 |
Houge G, Bruland O, Bjørnevoll I, Hayden MR, Semaka A. De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype. Neurology. 81: 1099-100. PMID 23946314 DOI: 10.1212/Wnl.0B013E3182A4A4Af |
0.628 |
|
2013 |
Semaka A, Kay C, Doty C, Collins JA, Bijlsma EK, Richards F, Goldberg YP, Hayden MR. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease. Journal of Medical Genetics. 50: 696-703. PMID 23896435 DOI: 10.1136/Jmedgenet-2013-101796 |
0.616 |
|
2013 |
Baine FK, Kay C, Ketelaar ME, Collins JA, Semaka A, Doty CN, Krause A, Greenberg LJ, Hayden MR. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes. European Journal of Human Genetics : Ejhg. 21: 1120-7. PMID 23463025 DOI: 10.1038/Ejhg.2013.2 |
0.607 |
|
2013 |
Semaka A, Balneaves LG, Hayden MR. "Grasping the grey": Patient understanding and interpretation of an intermediate allele predictive test result for huntington disease Journal of Genetic Counseling. 22: 200-217. PMID 22903792 DOI: 10.1007/S10897-012-9533-7 |
0.579 |
|
2012 |
Bombard Y, Semaka A, Hayden MR. Adoption and the communication of genetic risk: Experiences in Huntington disease Clinical Genetics. 81: 64-69. PMID 21204796 DOI: 10.1111/J.1399-0004.2010.01614.X |
0.504 |
|
2010 |
Semaka A, Collins JA, Hayden MR. Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles). American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 314-20. PMID 19455596 DOI: 10.1002/Ajmg.B.30970 |
0.634 |
|
2009 |
Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, Collins JA, Semaka A, Hudson TJ, Hayden MR. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. American Journal of Human Genetics. 84: 351-66. PMID 19249009 DOI: 10.1016/J.Ajhg.2009.02.003 |
0.65 |
|
2008 |
Semaka A, Warby S, Leavitt BR, Hayden MR. Re: Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1794-5; author reply. PMID 18548612 DOI: 10.1002/mds.21820 |
0.439 |
|
2006 |
Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clinical Genetics. 70: 283-94. PMID 16965319 DOI: 10.1111/J.1399-0004.2006.00668.X |
0.647 |
|
2006 |
Semaka A. Characterizing genetic wrinkles in sperm of advanced paternal age Clinical Genetics. 70: 307-309. DOI: 10.1111/J.1399-0004.2006.0675_2.X |
0.302 |
|
Show low-probability matches. |